PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis

被引：0
|
作者：
Theofilis, P. [1 ]
Papanikolaou, A. [1 ]
Vlachakis, P. K. [1 ]
Antonopoulos, A. S. [1 ]
Sagris, M. [1 ]
Oikonomou, E. [2 ]
Tsioufis, K. [1 ]
Tousoulis, D. [1 ]
机构：
[1] Hippokrateion Hosp, Athens, Greece
[2] Sotiria Reg Chest Dis Hosp, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis
    Wu, Zijia
    Gao, Lulan
    Lin, Zhihai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (01): : 452 - 465
  • [2] PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
    Chen, Ding-Qiang
    Xu, Wen-Bin
    Xiao, Ke-Yi
    Que, Zhi-Qiang
    Feng, Jin-Yi
    Sun, Nai-Kun
    Cai, Di-Xin
    Rui, Gang
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [3] PCSK9 Inhibitors Modify Plaque and Reduce Plaque Progression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Lima, Ana E.
    Boas, Gustavo Vilas
    Ferreira, Andre L. Carvalho
    Gonzalez, Maria Benitez
    Guida, Camila
    CIRCULATION, 2023, 148
  • [4] The benefits of PCSK9 inhibitors in patients with acute coronary syndrome:a systematic review and meta-analysis
    Guanzhao Zhang
    Shuting Chang
    Faming Zhao
    Xiangfeng Guan
    Zifan Nie
    Wenhao Liu
    Bo Li
    Emergency and Critical Care Medicine, 2024, 4 (01) : 28 - 34
  • [5] An Updated Meta-Analysis for Safety Evaluation of Alirocumab and Evolocumab as PCSK9 Inhibitors
    Choi, Hye Duck
    Kim, Ji Hae
    CARDIOVASCULAR THERAPEUTICS, 2023, 2023
  • [6] PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease
    Bittner, Vera A.
    Giugliano, Robert P.
    Brinton, Eliot A.
    Guyton, John R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) : 835 - 843
  • [7] EFFECT OF PCSK9 INHIBITORS ON CAROTID PLAQUE ECHOGENICITY
    Martinez-Martinez, M. M.
    Fernandez Travieso, J.
    Vazquez Ronda, M. A.
    Navarro Jimenez, G.
    De La Cruz Berlanga, E.
    Garcia Yubero, C.
    Olmedo Menchen, T.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 100 - 100
  • [8] Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
    Marfella, Raffaele
    Prattichizzo, Francesco
    Sardu, Celestino
    Paolisso, Pasquale
    D'Onofrio, Nunzia
    Scisciola, Lucia
    La Grotta, Rosalba
    Frige, Chiara
    Ferraraccio, Franca
    Panarese, Iacopo
    Fanelli, Mara
    Modugno, Piero
    Calafiore, Antonio Maria
    Melchionna, Mario
    Sasso, Ferdinando Carlo
    Furbattoj, Fulvio
    D'Andreaj, Davide
    Siniscalchi, Mario
    Mauro, Ciro
    Cesaro, Arturo
    Calabro, Paolo
    Santulli, Gaetano
    Balestrieri, Maria Luisa
    Barbato, Emanuele
    Ceriello, Antonio
    Paolisso, Giuseppe
    ATHEROSCLEROSIS, 2023, 378
  • [9] Safety and efficacy of PCSK9 inhibitors and effect on coronary plaque phenotype in statin-treated patients following acute coronary syndrome: a systematic review and meta-analysis
    Hakim, Dennis Ievan
    Qhabibi, Faqrizal Ria
    Yusuf, Muhammad
    Amar, Nasim
    Prasetya, Indra
    Ambari, Ade Meidian
    EGYPTIAN HEART JOURNAL, 2024, 76 (01):
  • [10] SAFETY AND EFFICACY OF PCSK9 INHIBITORS IN FAMILIAL HYPERCHOLESTEROLEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Shakir, Aamina
    Barron, Kyle
    Modi, Kalgi A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1820 - 1820
12345